A significant response to neoadjuvant chemotherapy in
BRCA1/ 2related breast cancer
PO Chappuis, J Goffin, N Wong, C Perret, P Ghadirian, PN Tonin, WD Foulkes

Supplementary Table 1 Breast cancer patients carrying a BRCA1/2 germline mutation and treated with neoadjuvant chemotherapy: clinicopathological characteristics and response to treatment
[View Table]

Supplementary Table 2 Breast cancer patients who do not carry a BRCA1/2 germline mutation, treated with neoadjuvant chemotherapy: clinico-pathological characteristics and response to treatment
[View Table]